Calypte Biomedical Corporation Awarded SFDA Approval of Oral HIV Diagnostic Test

Published: Apr 18, 2008

April 18, 2008 -- Calypte Biomedical Corporation (OTCBB: CBMC) of Portland, OR received SFDA approval for its oral HIV diagnostic test, Aware™ HIV-1/2 OMT (oral fluid). The test delivers results in 20 minutes with an accuracy comparable to lab tests. Aware is the only rapid oral fluid test approved for use in China. The test is being positioned as an alternative HIV test for medical sites that do not have access to a lab. The test is effective in detecting HIV-1 and HIV-2. More details...

Back to news